Bordetella pertussis (B. pertussis) is the causative agent of pertussis (whooping cough). 19 Since the 1990s, pertussis has re-emerged in the United States despite an estimated 20 95% vaccine coverage. Our goal was to characterize neutrophil responses and gene 21 expression profiles of murine lungs in the context of vaccination and B. pertussis 22 challenge. We utilized a bioluminescent neutrophil mouse model (NECre luc) to track 23 neutrophil recruitment. NECre luc mice were immunized with whole cell vaccine (WCV), 24 acellular vaccine (ACV), or a truncated adenylate cyclase toxoid (RTX) vaccine. 25 Neutrophil recruitment was measured in live mice across time and corroborated by flow 26 cytometry and other data. WCV immunized mice showed signs of neutrophilia in response 27 to B. pertussis challenge. Mice immunized with either ACV or WCV cleared the challenge 28 infection; however immunization with RTX alone was not protective. RNA sequencing 29 revealed distinctive gene expression profiles for each immunization group. We observed 30 an increase in expression of genes associated with responses to infection, and changes 31 in expression of distinct genes in each vaccine group, providing a complex view of the 32 immune response to B. pertussis infection in mice. This study suggests that combination 33 of immunological analysis with transcriptomic profiling can facilitate discovery of pre-34 clinical correlates of protection for vaccine development.
Introduction
immunization 31 , which he hypothesized was caused by PT, then known as leukocytosis-inducing group. This technique allowed for analysis of the diversity and frequency of the immunoglobulin 118 repertoire of immunized groups. We hypothesize that these approaches can continue to be 119 applied to other pathogen to host interactions to characterize the underpinnings to disease 120 progression and immunological responses. To characterize the effects of vaccination on neutrophil recruitment, NECre luc mice were 125 were similar to naïve infected mice, suggesting that RTX immunization did not improve bacterial 143 clearance ( Fig. 3abc) . 144
Analysis of serological responses of immunized mice. 145
As expected, the ACV immunized mice were protected against challenge as they rapidly 146 cleared the B. pertussis challenge dose (Fig. 3abc ). WCV immunized mice cleared B. pertussis, 147 but this response was delayed compared to the ACV mice. To determine the efficacy of 148 immunization on antibody production, we performed serology analysis. PT is a common antigen 149 of both the ACV and WCV and we observed a significantly higher concentration of anti-PT in the 150 ACV mice compared to the WCV (Fig. 3d ). Immunization of NECre mice with RTX with alum 151 adjuvant resulted in high anti-RTX antibody titers (Fig. 3e ) despite the fact that we did not see 152 increased clearance due to RTX immunization. In another study, we immunized CD1 mice with 153 RTX and alum adjuvant and we also saw no clearance of B. pertussis compared to non-154 vaccinated mice (data not shown). Our data suggest that, while immunization with RTX induces 155 antibody production, it is not sufficient to protect mice from B. pertussis infection as a single, 156 antigen vaccine. whole body luminescence in WCV immunized and challenged mice was significantly higher than 167 the whole body luminescence of naïve, ACV and RTX B. pertussis challenged mice at day 1 (Fig.  168   4d) . In general, luminescence signals of all groups decreased across days 2 and 4. However, in 169 the WCV group at day 6, we detected an increase in signal in the nasal cavity (71-fold) and the 170 whole body (47-fold) compared to naïve not challenged mice (Fig. 4de ). Due to variability between 171 animals, this increase was not significant compared to other groups. At this point WCV immunized 172 mice were morbid and required euthanasia. Taken together this data suggests that WCV 173 immunization prior to challenge resulted in increased neutrophil accumulation compared to other 174 vaccination groups. We next aimed to corroborate our IVIS luminescence data with flow cytometry 175 analysis of respiratory tissues. 176
Validation of neutrophil infiltration in respiratory tissue by flow cytometry
the WCV group, which directly correlates with the increased luminescence signals measured by 192 IVIS imaging (Fig. 4g) . 193 WCV immunized NECre luc mice induce a more robust Th1 immune response compared 194 to ACV immunized mice . 195 It has been previously documented that upon B. pertussis challenge, WCV immunized 196 mice elicit a Th1/Th17 immune response, similar to a naïve infection while ACV immunized mice 197 generate primarily a Th2 response [10] [11] [12] 34 . We hypothesized that similar responses are triggered 198 by WCV and ACV in the NECre luc model. To test this hypothesis, we determined the cytokine 199 profiles in lungs of immunized and challenged mice using electrochemiluminescent sandwich 200 immunoassays. The Th1 response was determined by increased levels of IFN-γ, IL-12p70, IL-1β 201 and TNF-α ( Fig. 5ab ), while the Th17 response was qualified by increased IL-17A and IL-6 ( Fig.  202 5cde). Th2 responses were associated to increased levels in As expected, we observed an increased Th1 response in the WCV vaccinated NECre luc 204 mice compared to the ACV group. We also observed an increase in the Th1 response in naive 205 challenged mice compared to non-challenged mice or the ACV group. Interestingly, the highest 206 levels of IL-17 were observed in WCV NECre luc mice (Fig. 5c ). The levels of Th2-associated 207 cytokines, IL-4 and IL5 were similar between the WCV and ACV groups. ( Supplementary Fig. 3 ). 208
The lung cytokine profile from NECre luc mice immunized with RTX resembled a profile of naïve 209 B. pertussis challenged mice with the exception of IL-6, which was lower in the RTX group. Taken 210 together these data from the NECre luc mouse model corroborates previous findings by displaying 211 a strong Th1/Th17 response in response to B. pertussis in WCV vaccinated mice. 212
Characterizing the gene expression profiles of the lungs of immunized and naïve mice after
Current and past B. pertussis immune response studies have focused on a limited set of 215 known immunological responses to B. pertussis challenge such as: bacterial burden, antibody 216 response, recruitment of phagocytes, cytokine profiles, and others 35, 36 . Whooping cough is a 217 toxin-mediated disease, due mainly to the activity of pertussis and adenylate cyclase toxins. 218
These toxins are released and affect a wide array of host cells 4,25 . It is therefore conceivable that 219 B. pertussis infection would have a broader effect on the respiratory tissue beyond the induction 220 of predictable immune response factors. To address this, we employed RNA sequencing 221 (RNAseq) to observe the effect of B. pertussis challenge on the lungs of immunized and naïve 222
NECre luc mice at a transcriptomic level. This allowed us to characterize the transcriptome 223 response to infection and vaccine-induced responses. We hypothesized that regardless of the 224 vaccine administered, we would identify a set of genes differentially regulated in all challenged 225 mice. Additionally, we sought to discern the unique gene expression profiles in response to 226 challenge in each immunized group. 227
To perform RNAseq analysis, lungs from NECre luc mice were harvested at an early time-228 point (day 1) following B. pertussis challenge and at a late time-point (day 6 or 9). RNA from the 229 lungs of the mice was isolated. Libraries were prepared and sequenced on the Illumina HiSeq 230 1500 platform. To characterize transcriptional responses to B. pertussis challenge in naïve or 231 vaccine mice (ACV, WCV, RTX), we compared the challenged samples to control mice that were 232 not immunized nor challenged. Based on this, we expected to determine both the immunological 233 (innate and adaptive) and the non-immunological responses to B. pertussis challenge. We 234 determined the differentially expressed genes (DEGs) for both early (day 1) and late (day 6 or 9 235 depending on group) time-points. The total numbers of differentially regulated genes are shown 236 in Fig. 6ac . Overall, there were more differentially genes at the later time-point than early after 237 challenge ( Fig. 6ac ). At day 1 post-challenge, the WCV group had the most genes activated ( Fig.  238 6a, Supplementary Fig. 5 ). Of the genes that were upregulated at day 1 in the WCV, 29.7% were not found upregulated in the other groups (464 of 1,560). At the late time-points, there were more 240 common upregulated genes and only 14.1% of the genes were unique to the WCV. We found 241 that 12.6% of unique upregulated genes (196) were common to all groups either challenged with 242 B. pertussis following immunization or naïve challenge, suggesting that these genes were 243 common to infection ( Fig. 6b) . At the later time-point, 19.8% of unique upregulated genes (867 of 244 6,595) were shared by the WCV, ACV, RTX groups, while this number was much lower at the 245 early time point (8.5% of DEGs, 133 of 1,560) ( Fig. 6bd ). Cumulatively, this data suggests that: 246 1) WCV vaccination induces a more diverse early response to B. pertussis challenge due to the 247 higher number of unique genes compared to other groups, and 2) at the later time-point all 248 vaccinated groups have a more similar lung transcriptome. 249
Ingenuity Pathway Analysis (IPA) was performed to determine enrichment analyses of 250 gene expression signatures in the context of each immunization. Using IPA Knowledge-based 251 enrichment analysis, statistically significant genes were grouped into disease and function 252 categories. A system of genes was considered enriched based on Fisher's exact test on the ratio 253 of represented genes. At the early time-point we, observed that the largest changes were 254 associated with genes involved in immune cell trafficking of the WCV group (Fig 7a) . Genes with 255 the highest fold changes within this system were associated with activation and migration of 256 leukocytes ( Fig. 7b ). Additionally, we observed significant enrichment of genes associated with 257 the humoral and cell-mediated immune responses ( Fig. 7b ). Pertussis toxin affects multiple 258 aspects of the cardiovascular system such as blood pressure, leukocyte migration, etc 7,37,38 . In 259 both naïve and immunized mice, we observed gene expression signatures related to 260 cardiovascular diseases ( Fig. 7ab ). ACV immunization results in high amounts of anti-PT 261 antibodies ( Fig. 4d ), and we observed fewer genes significantly altered in the ACV immunized 262 mice, suggesting positive effects of anti-PT antibodies on neutralization of toxin activity. At the RTX groups; however, the expression of these genes was still high in the WCV group. As 265 expected, immune-related gene signatures dominated the responses to B. pertussis infection. 266
However, thousands of genes significantly dysregulated due to infection at both time-points were 267 not related to immune response or were not sufficiently characterized to be assigned a function. 268
Analysis of the lung transcriptomes corroborated the findings of flow cytometry and cytokine 269 profile analyses, further supporting that there is an increase in leukocyte activity in the respiratory 270 tissue of WCV immunized mice compared to ACV or RTX immunized mice following B. pertussis 271 challenge. 272
Analysis of neutrophil-specific gene signatures 273
Since we observed that neutrophils accumulate in the lung of WCV immunized NECre luc 274 mice, we chose to delve further into the changes in expression of genes associated with neutrophil 275 activity. To compare the neutrophil response between the groups, we selected genes with GO 276 terms associated with neutrophil migration and activation and plotted the relative fold changes for 277 this subset of genes for each immunization group (Fig. 8 ). The expression levels of these genes 278 from either the naïve challenged, or immunized and challenged groups was compared to naïve, 279 not infected control mice (Fig. 8) . 280
Cxcl2 is a chemokine produced by monocytes and neutrophils at sites of infection 39 . 281
Previously it has been shown that convalescent mice previously challenged with B. pertussis 282 express lower amounts of cxcl2 when re-challenged with B. pertussis than naïve mice 40 . This 283 suggests that the adaptive responses in these mice negate the need for the innate production of 284
Cxcl2. Supporting this hypothesis, we observed the highest expression levels of Cxcl2 in naïve 285 and RTX immunized mice, which had similar bacterial burdens ( Fig. 7bd and Fig. 8be ). The 286 induction of Cxcl2 expression was lower in ACV vaccinated mice than naïve mice (Fig. 8ac ). The 287 expression of Cxcl2 also increased in the WCV mice, but remained high at the late time-point ( Fig. 8b ). Our serological analysis indicated that WCV immunization only induced minimal anti-289 PT production, whereas ACV induced high amounts of anti-PT ( Fig. 3d ). PT has been shown to 290 induce production of Cxcl2 in TY10 cerebral endothelial cells which further suggests a causal 291 relationship between non-neutralized PT and Cxcl2 production 41 . 292
All of the groups showed increases in a number of other C-X-C and C-C family chemokines 293 (cxcl3, cxcl1, ccl3, ccl4, ccl6, and ccl17). Cxcl1 gene expression was increased at day 1 in all 294 groups compared to the non-infected control (Fig. 8 ). We also observed an increase in IL-23 295 expression in the WCV group ( Fig. 7b ), which might be associated with the IL-17 cytokine 296 response measured in the WCV lung tissue. Tumor necrosis factor (tnf) gene expression was 297 increased in WCV, RTX, and ACV mice compared to non-infected mice. However, Tnf expression 298 levels decreased in ACV mice and were lower than those observed in uninfected mice at day 9 299 ( Supplementary Fig. 4 ). Ross et al. demonstrated that IL-17A promotes production of CXCL1 300 during B. pertussis challenge 10 . In our cytokine analysis, only the WCV mice had sufficient IL-17 301 to be detected in the lung homogenates ( Fig. 5c ). Taken together these data suggest that although 302 we did not observe high IL-17A gene expression in the transcriptome or in the IL-17 cytokine 303 analysis, there could still be sufficient IL-17A in the Naïve, ACV, and RTX challenged mice that 304 could account for the increased Cxcl1 gene expression. 305
We observed that S100a9 and S100a8 were highly upregulated in WCV and RTX groups 306 ( Fig. 7 and Fig. 8b ). S100a9 is a major calcium-binding protein of neutrophils, which forms a 307 heterodimer with S100a8, and promotes polymerization of microtubules. Interestingly, S100a8/a9 308 is produced mainly by neutrophils and high plasma levels of S100a8/a9 correlate with higher 309 blood neutrophil blood levels in heathy human adults 42 . S100a8/a9 promotes transendothial 310 phagocyte migration by promoting tubulin polymerization 43 . Additionally, monocytes isolated from 311 human patients with cardiac injury have been found to be particularly responsive to S100a8/a9 chemotaxis and adherence, but PT can block this function of S100a8/a9 45 . These data suggest 314 that PT induction of leukocytosis may be related to the role of S100a8/a9 in leukocyte recruitment. 315 S100a8/a9 expression was lowest in the ACV mice which had the highest amount of serum anti-316
PT. 317
Overall the WCV mice had higher expression of more neutrophil genes than any of the 318 other groups (Fig. 7) . Expression of these neutrophil signatures did not return to uninfected levels. 319
These observations corroborates IVIS ( Fig. 4de ) and flow cytometry analyses (Fig. 4fg) . 320
Neutrophil gene expression in ACV mice was dynamic and returned to levels lower than 321 uninfected mice by day 9. ACV mice did not have detectable B. pertussis in their lungs at day 9, 322
indicating that the initial challenge does had been cleared ( Fig. 3 ). ACV and WCV signatures 323
were the most dissimilar, while the RTX and naïve mice transcriptome profiles were the most 324 similar (Fig. 7) . This correlates with the fact that RTX mice still have detectable B. pertussis in 325 their nares, trachea and lungs at day 9 at levels similar to those observed in non-vaccinated mice. 326
These data confirm our neutrophil observations but also enhance our analysis of the neutrophil 327 dynamic in the context of vaccination status and B. pertussis challenge. 328
B cell gene expression signatures in relation to immunization status. 329
It has been established that B cells are required for the clearance of B. pertussis in mice 330
and that ACV immunization protects through neutralizing antibodies 46,47 . To further investigate 331 antibody production between WCV and ACV immunized mice, we aimed to determine the 332 diversity of B cell clone expansion between vaccinated and non-vaccinated challenged mice. 333
Using MiXCR software, the same illumina sequenced reads mentioned above were analyzed 334 specifically for immunoglobulin profiling 48 . Individual B cell clones were identified by B cell 335 receptor sequence and clonal expansion was accessed by immunoglobulin diversity and groups. At the early time-point day 1 post-challenge, immunoglobulin diversity and frequency of 338 B cells depicted a close relation between the ACV and RTX vaccination groups, as also did WCV 339 and naïve challenged mice ( Supplementary Fig. 6a ). This response shifted by the late time-point 340 (days 6 or 9), when we observed that WCV and ACV groups were more similar. Using this 341 approach, we were able to determine the individual variable and joining segments abundance, 342 and the frequency of which a particular was found. Not surprisingly, we observed the highest 343 degree of diversity at the late time-point. WCV and ACV were the most similar due to a higher 344 number and abundance of clonotypes ( Supplementary Fig. 6b ). We focused our analysis on the 345 diversity of the third complementarity-determining region (CDR3) of the heavy Ig chain, because 346 this region has been shown to be necessary for antigen specificity 49 . The highest abundant CDR3 347 region sequence, NQHLFW, was present only in the WCV immunized mice, while the other 10 348 highest CDR3 regions were shared across vaccine groups at the early and late time-points 349
( Supplementary Table 6 and Supplementary Table 7 ). Together this data suggests that clones 350 generated from acellular based vaccines (ACT and RTX) are more closely related because they 351 are generated to a limited number of antigens. However, by the late time-point, proliferation of 352 specific B cell clones generated from WCV has created the same diversity seen in the ACV 353 clones. The B cell clonotype analysis suggests that we can aim to further understand these 354 populations in the future but we will need to increase our sequencing depth by directly isolating 355 the cell populations from the immunized mice instead of analyzing the full lung tissue. It may also 356 be interesting to probe the T cell receptor clonotypes using the same method. 357
Discussion 358
In this study, we compared the innate and adaptive immune responses of immunized 359
NECre luc mice vaccinated with ACV or WCV vaccines, to mice immunized with a truncated ACT 360 toxin absorbed to alum (RTX), or non-vaccinated naïve mice following challenge with B. pertussis.
were observed. We also determined that the RTX antigen alone was not protective as a single 363 antigen vaccine with alum adjuvant in NeCre luc mice. We utilized IVIS imaging to track the 364 recruitment of neutrophils to the respiratory tract of challenged mice from days 1 to 9 post-365 challenge. The data obtained illustrated a dramatic increase in the amount of neutrophils recruited 366 to the lungs and nasal cavity of WCV immunized mice compared to ACV immunized mice when 367 followed by B. pertussis challenge. These data were also supported by flow cytometry and 368 cytokine analysis. Furthermore, by performing RNA sequencing on the lung transcriptome during 369 infection in vaccinated or naïve mice, we described unique gene expression profiles depending 370 on the vaccination status of the mice. We also used RNA sequencing to begin to describe the 371 immunoglobulin diversity induced by each vaccine. 372
Upon initial B. pertussis challenge, we observed activation of neutrophil associated genes in all 373 groups, however it was only in the WCV immunized mice that we saw increased neutrophil genes 374 expression still elevated at the late time-point. Neutrophilia and elevated neutrophil related genes 375 expression at the late time-point, when bacterial numbers in the airways are greatly reduced, 376
indicates either over activation of neutrophil "chemokine storm," or possibly a lack of neutralization 377 of bacterial toxins. Multiple studies suggest that PT is responsible for neutrophilia and 378 leukocytosis following B. pertussis infection 13, 32, 50, 51 . Immunization with the ACV induced 1,146-379 fold more anti-PT antibody production than WCV immunization at day 2 ( Fig. 3d ). It is possible 380 that the low levels of anti-PT production in WCV mice resulted in insufficient neutralization of PT, 381 resulting in exacerbated neutrophilia. Surprisingly, the highest neutrophil accumulation was 382 determined at day 6 post-challenge when bacterial levels were similar to those of ACV protected 383 mice (Fig. 3) . These findings suggest that while WCV immunization is protective at clearing 384 infection in NECre luc mice, it also induced severe neutrophilia. Interestingly, the neutrophil 385 response in WCV mice decreased at days 2 and 4 but highly increased at day 6 ( Fig. 4) . At day 386 2, we observed a significant increase in IL-17 in the lungs of WCV mice (Fig. 5c ) that could result 387 from the increased IL-17 expression in these mice. Stephen Morse observed dose-dependent leukocytosis in mice following vaccination with killed B. pertussis 31 . In this study, NECre luc mice 389 were immunized with 1/5 th the human dose of WCV. We now realize that this dose is likely well 390 above the proportional weight of a mouse compared to a human. It is possible that this high 391 vaccine dose induced the hyper leukocytosis, similar to the dose-dependent increase that Morse 392 observed. It is known that hyperleukocytosis is associated with death in infant cases, and that PT 393 is responsible for inducing leukocytosis 1,7,52 . Furthermore, mice and baboons infected with B. 394 pertussis and then treated with anti-PT antibodies had lower levels of leukocytosis compared to 395 non-infected controls 50 . An epidemiological study found that in unvaccinated individuals with 396 pertussis, 72% of patients experienced leukocytosis 53 . In this study, we observed that WCV 397
immunized NECre luc mice experienced neutrophilia and morbidity, which highlights the potential 398 issues of using WCVs. It would be interesting to determine the relationship of neutrophilia and 399 WCV immunization in epidemiological past studies but we have not been successful in identifying 400 a study that specifically looked at neutrophilia because studies most note general leukocytosis. 401
In NECre luc mice, the ACV was clearly more protective and less detrimental to the mice 402 than the WCV. Truncated and full-length ACT purified from B. pertussis culture has been shown 403 to be a protective antigen 21 . Wang et al. described the RTX region of ACT as highly immunogenic 404 and easily purified as a recombinant protein 22 . We have observed that immunization of CD1 mice 405 with RTX and alum adjuvant results in high anti-RTX titers (data not shown). Here, we immunized 406
NECreluc mice with RTX and alum, but no protection was observed (Fig. 3abc) . The previous 407 studies were performed with strain 18323 and the antigen was directly isolated from B. 408 pertussis 21,54 . It is now known that strain 18323, is an outlier compared to most other global B. 409 pertussis strains and Guiso et a 21 l. noted that strain 18323 produces less PT than the Tohama I 410 type strain. From our work, we know that UT25 produces more PT and ACT than Tohama I (data 411 not shown). It is possible that due to the increased PT levels produced by UT25, vaccination with 412 pro-inflammatory cytokine IL-6 in the RTX group compared to not vaccinated and WCV 415 vaccinated and challenged mice (Fig. 5e ). PT and ACT have both been shown to induce the 416 production of IL-6 in human cell lines 55, 56 . The anti-ACT antibodies generated by RTX vaccination 417 may play a role in reducing the levels of IL-6 due to reducing the activity of ACT. We hypothesize 418 that it is necessary to neutralize both PT and ACT to provide optimal protection and in future 419 studies, we will test RTX as an antigen in a multivalent ACV containing PT antigen. infected with B. pertussis exhibited higher expression of these chemokines compared to naïve 432 mice, similar to our whole cell transcriptome where these chemokines are consistently higher than 433 the naïve mice ( Fig. 7 and Fig. 8) . We observed the highest expression of these chemokines in 434 the naïve and RTX mice groups, where these groups had a similar gene profile of genes belonging 435 to the immune cell trafficking and cardiovascular disease annotations (Fig. 7) . These findings, 436 along with higher bacterial burden (Fig. 3) suggest that RTX-alum immunization does not provide 437 sufficient protection. Fig. 4 ), we then sought to specifically characterize B cell clone diversity. The RNAseq reads were 441 re-processed with the MiXCR algorithm and we analyzed the abundance and diversity of VDJ 442 clonotypes ( Supplementary Fig 5) . Besides the T cell response differences of the ACV and WCV 443 (Th2 v. Th1/Th17) another significant difference between these two vaccines is the number of 444 antigens. ACVs have 3-5 antigens (PT, FHA, PRN, FIM2/3) but the WCV hypothetically has 445 ~3,000 antigens. In light of this, it would be logical to hypothesize that the WCV would induce a 446 vast antibody repertoire as measured by many VDJ clonotypes. However, we observed a greater 447 diversity and abundance in the ACV group compared to the WCV at both early and late time-448 points ( Supplementary Fig. S6 ). It is important to point out that this analysis was performed on 449 total lung RNA. If we were to isolate B cells and sequence deeper we would expect to more 450 thoroughly characterize the repertoire. These data are interesting but we do not know which clone 451 types result in functional antibodies that protect against B. pertussis. Further analysis is required 452 to bridge the gap between clonotypes and functional/protective antibodies. 453
Using NeCRE luc mice, we performed tracking neutrophil recruitment during a B. pertussis 454 respiratory infection. These data demonstrate how analysis of cellular responses through in vivo 455 imaging can be used to provide a quantitative parameter throughout a study. This model can be 456 applied to other bacterial infection models or cancer tumor progression models where following 457 the same mouse throughout a study would be beneficial. In this study, we also added next 458 generation sequencing technology to expand upon the immunological findings. RNAseq analysis 459 can be further employed to understand key cell populations and how they are impacted by both 460 immunization and B. pertussis challenge. Our current goal is to continue to refine the murine 461 O-methyl)-β-cyclodextrin). SSM cultures were grown for ~22 h at 36°C with shaking at 180 rpm 472 until the OD600 reached 0.5 on a 1 cm path width spectrophotometer (Beckman Coulter DU 530) . 473
The cultures were then diluted to 1 x 10 9 / ml with SSM. 474
Mouse Strains 475
All mouse strains used were bred in a specific pathogen-free experimental conditions within the 476
Office of Laboratory Animal Resources vivarium at West Virginia University. Mice were aged 8 -477 12 weeks, male and female sex mice were equally assigned to all vaccination groups. 129-478
Elane tm1(cre)Roes /H mice (Medical Research Council, London, UK) were crossed with 479 FVB.129S6(B6)-Gt(ROSA)26Sortm1(luc)kael/J mice (Jackson labs; 0051225) resulting in NECre 480 luc progeny. NECre luc mice were injected with CycLuc 1 lucferin (EMD Millipore, Darmstadt, 481
Germany) and confirmed to be luminescent using Xenogen Lumina II 61 . Upon intraperitoneal 482 injection of a luciferase substrate (luciferin), neutrophils emit luminescence that is detectable 483 using a high sensitivity live animal imaging system (Xenogen IVIS Lumina II). 484
Vaccines used in study and administration 485
All vaccines were formulated into 200 µl doses with the antigen content described below. 100 µl 486 of INFANRIX (GSK) human vaccine (DTaP) which is 1/5 human dose of the vaccine, was mixed 487 in 100 µl of PBS. The NIBSC WHO standard Bordetella pertussis whole-cell vaccine (NIBSC code 488 94/532) was received lyphophilzed and reconstituted in 1ml of PBS. At this concentration one human dose is 100 µl therefore, 20 µl was mixed with 180 µl of PBS, which is 1/5 of the human 490 dose (66 µg of total protein). A truncated ACT protein (RTX) was purified as previously described 491 purified RTX or Pt in PBS at a concentration of 1 µg/mL. Purified B. pertussis antigens, were 562 obtained from Dr. Jennifer Maynard. Serum samples from NVNC, PBS, ACV, and WCV serum 563 titers were analyzed for PT, as the RTX group had no PT in vaccine. Samples from NVNC, PBS, 564 WCV, and RTX were analyzed for serum antibody titers to RTX, as ACV would not be expected 565
to have RTX titers because no RTX was included in vaccine. Plates were then washed with PBS 566 + 1% Tween 20 (PBS-T), then blocked with 5% milk in PBS-T for 1 hour at room temperature. 567
Sera were diluted to a concentration in the linear dose range for each antigen. Plates were 568 incubated for 2 h at 37⁰C with serial diluted serum samples from vaccinated groups. Following 3 569 PBS-T washes, 1:4000 goat anti-mouse IgG-AP (Southern Biotech), secondary antibody was 570 added and incubated 1 h at 37⁰C. Plates were washed, then developed for 30 min with 100 µl p-571 nitrophenyl phosphate. Colorimetric signal was measured using Spectramax i3 (Molecular 572
Devices) at 450nm. An average of blanks was subtracted from all absorbances and used as a 573 baseline detection limit. The minimum detection limit above the baseline was analyzed by one-574 way ANOVA, with a Tukey's multiple-comparison test for each time-point using Prism 7. 575
Isolation of Lung RNA, illumina library preparation, and sequencing 576
Lung RNA was prepared similar to previously reported 62 with the following modifications. The 577 freshly isolated NECre luc mice lungs were homogenized and RNA was prepared immediately 578 using RNeasy purification kit (Qiagen). Each lung was placed in 1 ml of sterile PBS and then 2 ml 579 of TE lysozyme (1mg/ml) was added and allowed to incubate for 10 min on ice. 2 ml of RLT buffer 580 was added and incubated for another 10 min on ice. The homogenate was then pushed through 581 a syringe needle. The homogenates were pelleted by centrifugation at 20,800g (max speed 582 microfuge) for 10 min. The supernatant was extracted and then 2.8ml of 100% EtOH was added 583 to each tube. This supernatant of each mouse sample was then disturbed to four RNeasy tubes 584 for RNA isolation. The RNA was eluted and pooled into one sample per mouse. The resulting 585 RNA integrity was assessed using Agilent BioAnalyzer RNA Pico chip. All samples were then 587 submitted Ribo-zero rRNA depletion (illumina) and reassessed for RNA integrity. rRNA depleted 588 mRNA samples were then fragmented and prepared into libraries using illumina ScriptSeq 589
Complete Gold (Epidemiology). Libraries were checked for quality control with KAPA qPCR QC 590 assay (KAPA Biosystems). The libraries (33 total) were then sequenced on an illumina HiSeq at 591 the Marshall University Genomics Core facility on 2 lanes of 2x50B. pertussis. Sequencing data 592 were deposited to the Sequence Read Archive (SRA) and are available under the reference 593 number SRA587785, BioProject number PPJNA394758. 594
Pathway Enrichment Analysis 612
Ingenuity Pathway Analysis (Qiagen) was utilized to map lung transcriptomes to biological and 613 disease functions. Lung transcriptomes were loaded to IPA, and comparative analyses were 614 performed at early and late time-points. Gene expression fold-changes were mapped to higher-615 order disease and function defined by the IPA knowledge base, and a gene enrichment analysis 616 was performed on early and late time-points. A Fisher Exact T-test was used to determine 617 statistically significant (p < 0.05) p-values of the functions that made up the higher-order disease 618 category and represented as a range of p-values. The relative fold-change of these identified 619 genes was determined, and the 10 highest fold-changes were represented as heat maps. analysis method on days 1,2,4, 6, and 9 days pc in NECre luc mouse model. Mice were initially 681 vaccinated and then given a booster dose of the same vaccine at day 21. A challenge dose of 2 682
x 10 7 viable bacteria was administered by intranasal inhalation at day 35. IVIS imaging of 683 neutrophils was monitored throughout study. The overall numbers of mice per group are indicated. 684
At time-points shown bacterial burden, complete blood cell counts, lung cytokine profiles, lung 685 and nasal wash neutrophil cells, serum antibody titers, and lung transcriptome were determined. 686
To characterize the effects of vaccination, the vaccinated groups were compared to a group of 687 lung on BG agar. The dashed line at 1000 CFUs represents the lower limit of detection, due to 703 plating. Data in each group were compared to PBS control using an unpaired two-tailed t-test. 704
Significant differences are not indicated on the graphs for clarity ( Supplementary Table 2 neutrophils (GR-1+CD11b+) detected in nasal lavage (f) and lung homogenate (g). Significant 720 differences are not indicated on the graphs for clarity, but are included in Supplementary Table 3 . 
